AGM/EGMApr 30, 2026, 05:01 PM
ELDN to Increase Authorized Shares to 450M; Annual Meeting Set
AI Summary
Eledon Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will take place on June 18, 2026. Stockholders will vote on the election of three Class III directors, an amendment to increase authorized common stock from 300,000,000 to 450,000,000 shares, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026. The record date for voting is April 20, 2026, with 77,187,823 shares outstanding.
Key Highlights
- Annual Meeting of Stockholders to be held on June 18, 2026, at 11:30 a.m. Pacific Time.
- Record date for voting is April 20, 2026.
- Proposal to elect David-Alexandre C. Gros, M.D., Jan Hillson, M.D., and James Robinson as Class III directors.
- Proposal to increase authorized common stock from 300,000,000 to 450,000,000 shares.
- Proposal to ratify Deloitte & Touche LLP as independent auditor for 2026.
- 77,187,823 shares of common stock outstanding and entitled to vote as of record date.
Price Impact
More from ELDN